Title:Senior Consultant
Degree/diploma:Ph.D., M.D.
Areas of focus:
Stereotactic radiotherapy for early lung cancer and various metastatic tumors;
Radiotherapy and chemotherapy for common tumors such as advanced lung cancer and esophageal cancer, etc.;
Postoperative adjuvant radiotherapy and chemotherapy for breast cancer and urogenital system tumors;
Radiotherapy and chemotherapy for common head and neck tumors, such as nasopharyngeal carcinoma, laryngeal cancer, etc.
Biographical sketch
Dr. LIU Hai obtained his doctoral degree in oncology at Zhejiang University School of Medicine in 2011 and has worked at SRRSH after graduation. He specializes in radiotherapy and chemotherapy of common malignant tumors, especially precision radiotherapy. During his studies, he completed the research and training in clinical medicine, imaging medicine and clinical oncology. He made great efforts to apply modern precision radiotherapy technology to treat tumors, including intensity modulated radiation therapy (IMRT), Stereotactic body radiation therapy (SBRT), etc. He can skillfully apply a variety of comprehensive treatment methods such as chemotherapy, targeted therapy and immunotherapy. He has been responsible for or participated in multiple national and provincial medical research projects and has published dozens of papers in the fields of tumor radiotherapy sensitivity prediction and radiotherapy sensitization.
Professional memberships
Member of the Radiotherapy Committee, Zhejiang Medical Doctors Association
Member of the Special Committee on Urological Oncology, Zhejiang Medical Doctors Association
Member of the Youth Committee for Nasopharyngeal Cancer, Zhejiang Anti-Cancer Association
Member of the Committee on Anti-Cancer Drugs, Zhejiang Anti-Cancer Association